Instrument Inactif

Autres langues Lotus Pharmaceuticals, Inc. Other OTC

Actions

LTUS

US5457152032

Produits pharmaceutiques

Autres langues

30/12	Lotus Pharmaceutical Supports Street Medicine Program to Expand Access to Care for Those Most in Need
06/10/25	Lotus Enters License and Supply Agreement with Adalvo for Semaglutide injection
12/08/25	Lotus Pharmaceutical Achieves New First-Half Record in Revenue for 2025, While Q2 Impacted by FX and Timing of Lenalidomide Sales
21/02/25	Lotus announces FDA acceptance of Potential First-to-File ANDA Submission for Voclosporin soft gelatin capsules, a generic equivalent to Lupkynis
08/11/24	Lotus Achieves Second-Highest Quarterly Performance in Company History with 3Q24 Financial Results
08/07/24	Lotus Pharmaceuticals Secures Three HR Asia Awards for 2024
07/06/24	Lotus Pharmaceuticals announces the acquisition of Teva Pharma Thailand, expanding its footprint in Southeast Asia
10/11/23	Lotus Achieves Historic Q3 2023 Results with YTD EPS Soaring to a Record NTD 14.19 Marking a 29% Year-on-Year Growth
12/09/23	Lotus Continued Stelar Growth in 2Q 2023 EPS Recorded NTD 4.85 with 285% Growth Year on Year
14/08/23	Lotus Continued Stelar Growth in 2Q 2023 EPS Recorded NTD 4.85 with 285% Growth Year on Year
01/08/23	AMARIN AND LOTUS PHARMACEUTICALS ANNOUNCE EXCLUSIVE PARTNERSHIP AGREEMENT TO COMMERCIALIZE VAZKEPA IN SOUTHEAST ASIA AND SOUTH KOREA
31/07/23	Amarin, Lotus Pharmaceuticals Agree to Exclusive Vazkepa Distribution Deal in 10 Asian Countries
27/03/23	Lotus Announces MFDS Approval for GRALISE SR, Once-Daily Tablets for Post-Herpetic Neuralgia
13/03/23	Lotus revenues grow by 16% and profit doubles year over year
14/12/22	Lotus acquires Alimta in Taiwan from Lilly
12/07/22	Lotus Pharmaceuticals - Aztiq and Innobic officially become Lotus's majority shareholders
16/05/22	Lotus Reports Solid Performance in First Quarter of 2022
30/03/22	Lotus Pharmaceuticals : Unaudited Financial Statement
23/03/22	Lotus Pharmaceuticals acquires Cialis (Tadalafil) in Taiwan from Lilly
17/03/22	Lotus achieves another record high EPS for FY2021
29/11/21	A powerful investment alliance of Aztiq and Innobic acquires Alvogen's shares in Lotus and Adalvo in a US$475m deal
26/11/21	Thai oil firm PTT expands pharma business with $475 million Alvogen deal
22/11/21	Lotus Pharmaceuticals : Informational Disclosure
22/11/21	Lotus Pharmaceuticals : Unaudited Financial Statements
28/09/21	Lotus Pharmaceuticals : Temasek-backed Vertex expects at least $400 million in new S.E.Asia/India fund